From £7.99 per month
ShareProphets
The one stop source for breaking news, expert analysis, and podcasts on fast-moving AIM and LSE listed shares

MINDING THE LSE’S BUSINESS

Join for as low as £7.99 per month

With ShareProphets’ membership, you receive:

• All premium articles

• Tom Winnifrith’s Bearcast

• Access to all the entire nearly 10 year archive

• ShareProphets Daily Newsletter

Selective fascist censorship on LSE Asylum as bear raider Waseem Shakoor lets rip again on the Cloudtag fraud

By Tom Winnifrith | Tuesday 7 February 2017


Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours. I wrote this article myself, and it expresses my own opinions. I am not receiving compensation for it (other than from ShareProphets). I have no business relationship with any company whose stock is mentioned in this article.


Bear raider Waseem Shakoor has let rip again on the fraud Cloudtag (CTAG). The great Waseem, currently recovering from a sporting injury common among middle aged athletes, has served up a real reality check to the morons on how quickly, if ever, Onitors appear in British stores. This is a strong follow up to yesterday's coke penis photo report from the Spring Fair. What is fascinating is how the LSE Asylum is applying selective censorship of Waseem who says that he has received a message from LSE asking me to refrain from saying "I've spoken to a Cloudtag source" as it couldn't be verified. Since when did everything you write on a bulletin board have to be verified asks the Bear. Indeed. Waseem's two posts, which will no dount be removed altogether soon, read:


Filed under:



Subscribe to our newsletter

Daily digest of our latest stories.



Search ShareProphets

Market News

Complete Coverage

Recent Comments

That Was the Week that Was

Saturday »

AVCT

Cassava, A warning to Avacta Sharehoders 

Friday »

ALU

Alumasc Group – a growth Buy

 

VCP

Victoria - The roll up unravels

 

HEMO

Hemogenyx is a short – target 0p

 

ECR

ECR, the timing is unfortunate

 

APH

Alliance Pharma – a recovery Buy?

Time left: 04:32:34